Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Former FBI Director Robert Mueller has Parkinson’s disease: report

by admin September 1, 2025
September 1, 2025
Former FBI Director Robert Mueller has Parkinson’s disease: report

Former FBI Director Robert Mueller was diagnosed with Parkinson’s disease, his family revealed to the New York Times.

Mueller is the former special counsel who led the Russia investigation into President Donald Trump’s 2016 campaign.

Mueller, 81, was diagnosed in 2021 and retired from public life the following year after briefly teaching law, according to a family statement provided to The Times.

‘Bob was diagnosed with Parkinson’s disease in the summer of 2021. He retired from the practice of law at the end of that year. He taught at his law school alma mater during the fall of both 2021 and 2022, and he retired at the end of 2022,’ the statement said.

This post appeared first on FOX NEWS

previous post
Commencement of Henbury Field Program
next post
Trump says he will require voter ID with executive order

Related Posts

Russia looks to update nuclear program amid ‘colossal...

August 25, 2025

Why Trump, rightly praised for the Gaza ceasefire,...

October 16, 2025

Trump secures record-shattering $1.4B for political war chest,...

June 28, 2025

Ernst demands $2T in federal cuts, urges Trump...

October 4, 2025

Democrats begin to embrace Musk amid Trump spat...

June 6, 2025

How AI browsers open the door to new...

September 21, 2025

Trump issues warning about wasteful spending, orders ‘radical...

February 19, 2025

Tariff case pits Cato Institute against Trump over...

July 9, 2025

Hegseth quips ‘99.9%’ of DEI initiatives are gone...

April 11, 2025

Hakeem Jeffries’ 4-word answer to why he skipped...

September 17, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved